Close Menu

NEW YORK (GenomeWeb) – SeraCare Life Sciences has announced a collaboration with the US National Institute of Standards and Technology (NIST) to develop circulating tumor DNA (ctDNA) reference standard materials for diagnostics.

Under the terms of the three-year cooperative research and development agreement, SeraCare will provide its Seraseq ctDNA reference material technology to NIST for the development of digital PCR measurement methodologies. NIST will distribute these materials to various laboratories and will compare their results.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The chief executive of the National Health Service in England is to call for tumor-agnostic drugs to be "fast-tracked," according to the Times.

Researchers in Australia are sequencing the Wollemi pine tree to try to protect it from extinction, Australia's ABC News reports.

Computerworld ranks Illumina as one of the top midsize organizations to work at in IT.

In Genome Research this week: links between biological aging and mutations affecting epigenetic regulators; long-read sequencing-based strategy to map chromatin accessibility; and more.